Masaru Kubota

2.3k total citations
90 papers, 1.7k citations indexed

About

Masaru Kubota is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Masaru Kubota has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 43 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Masaru Kubota's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (19 papers) and Colorectal Cancer Treatments and Studies (10 papers). Masaru Kubota is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (19 papers) and Colorectal Cancer Treatments and Studies (10 papers). Masaru Kubota collaborates with scholars based in Japan, Australia and United States. Masaru Kubota's co-authors include Hirosuke Kobayashi, Minoru Kanazawa, Philip H. Quanjer, Hisamitsu Omori, Koichiro Tatsumi, T. John Martin, J. M. Moseley, John A. Heath, Peter R. Ebeling and I. W. Caple and has published in prestigious journals such as Journal of Geophysical Research Atmospheres, PLoS ONE and Diabetes.

In The Last Decade

Masaru Kubota

88 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaru Kubota Japan 18 606 473 285 229 173 90 1.7k
Yuka Yamamoto Japan 34 1.0k 1.7× 483 1.0× 378 1.3× 309 1.3× 463 2.7× 258 3.7k
Kenneth Russell United States 32 1.8k 3.0× 678 1.4× 459 1.6× 174 0.8× 178 1.0× 120 3.5k
Pasquale Esposito Italy 32 303 0.5× 268 0.6× 516 1.8× 358 1.6× 643 3.7× 218 3.6k
Michael H. Johnson United States 30 1.9k 3.1× 348 0.7× 1.4k 4.7× 89 0.4× 204 1.2× 127 3.5k
J. M. Bridges United States 26 123 0.2× 266 0.6× 250 0.9× 138 0.6× 110 0.6× 113 2.4k
Yaping Wang China 23 275 0.5× 110 0.2× 697 2.4× 84 0.4× 156 0.9× 86 1.8k
Yves Rees United Kingdom 16 302 0.5× 78 0.2× 174 0.6× 97 0.4× 153 0.9× 46 1.2k
C. Lacombe France 34 252 0.4× 538 1.1× 1.3k 4.7× 487 2.1× 147 0.8× 121 4.0k
Donald W. Weaver United States 31 537 0.9× 898 1.9× 591 2.1× 75 0.3× 355 2.1× 122 3.1k
Takeshi Ishizaki Japan 28 1.1k 1.8× 206 0.4× 395 1.4× 466 2.0× 282 1.6× 140 2.4k

Countries citing papers authored by Masaru Kubota

Since Specialization
Citations

This map shows the geographic impact of Masaru Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Kubota more than expected).

Fields of papers citing papers by Masaru Kubota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Kubota. The network helps show where Masaru Kubota may publish in the future.

Co-authorship network of co-authors of Masaru Kubota

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Kubota. A scholar is included among the top collaborators of Masaru Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Kubota. Masaru Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Igawa, Satoshi, Tomoya Fukui, Jiichiro Sasaki, et al.. (2020). Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors. Investigational New Drugs. 38(3). 885–893. 14 indexed citations
2.
Igawa, Satoshi, Takaaki Ono, Tetsuya Ozawa, et al.. (2019). EP1.01-68 Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study. Journal of Thoracic Oncology. 14(10). S938–S938. 1 indexed citations
3.
4.
Nakahara, Yoshiro, Tomoya Fukui, Masayuki Shirasawa, et al.. (2018). Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma. Internal Medicine. 57(21). 3149–3152. 1 indexed citations
5.
Igawa, Satoshi, Masayuki Shirasawa, Hideyuki Sone, et al.. (2018). Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status. Thoracic Cancer. 9(8). 967–973. 8 indexed citations
6.
Igawa, Satoshi, Masaaki Ichinoe, Sakiko Otani, et al.. (2017). Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations. Oncology Research and Treatment. 40(1-2). 7–13. 8 indexed citations
7.
Kasajima, Masashi, Satoshi Igawa, Sakiko Otani, et al.. (2017). Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer. Oncology Letters. 13(3). 1719–1724. 4 indexed citations
8.
Igawa, Satoshi, Sakiko Otani, Yoshiro Nakahara, et al.. (2017). Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer. Investigational New Drugs. 36(1). 45–52. 3 indexed citations
9.
Kubota, Masaru. (2016). [Diagnosis and examination for COPD. Pulmonary function tests].. PubMed. 74(5). 763–7. 1 indexed citations
10.
Fukushima, Daisuke, K. Shiokawa, Yuichi Otsuka, et al.. (2015). Geomagnetically conjugate observation of plasma bubbles and thermospheric neutral winds at low latitudes. Journal of Geophysical Research Space Physics. 120(3). 2222–2231. 27 indexed citations
11.
Kubota, Masaru, Michi Nishioka, Takuya Tsugawa, & Mamoru Ishii. (2014). An Ionospheric Response to the 2013 Moore EF5 Tornad, Detected By High-Resolution GPS-TEC Observations. AGUFM. 2014. 1 indexed citations
12.
Igawa, Satoshi, Shinichiro Ryuge, Tomoya Fukui, et al.. (2010). Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer. International Journal of Clinical Oncology. 15(5). 447–452. 13 indexed citations
13.
Fukui, Tomoya, Sakiko Otani, Ryuji Hataishi, et al.. (2009). Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease. Cancer Chemotherapy and Pharmacology. 65(4). 803–806. 28 indexed citations
14.
Yokoba, Masanori, et al.. (2006). [Recurrent pulmonary edema associated with obstructive sleep apnea syndrome].. PubMed. 44(11). 812–6. 2 indexed citations
15.
Ishii, Mamoru, et al.. (2004). Vertical wind distribution in the polar thermosphere during Horizontal E Region Experiment (HEX) campaign. Journal of Geophysical Research Atmospheres. 109(A12). 17 indexed citations
16.
Yoshida, Naoki, et al.. (2003). Characteristics of the Corotating Aurora Observed at Poker Flat (Extended Abstract). The science reports of the Tohoku University. 36(4). 514–518. 1 indexed citations
17.
Lin, Ying‐Wei, Shin Okazaki, Kenichiro Watanabe, et al.. (1999). Acute pure red cell aplasia associated with allopurinol therapy. American Journal of Hematology. 61(3). 209–211. 1 indexed citations
18.
Kubota, Masaru, et al.. (1995). Comparative Effect of 100 Versus 250 μ/m2/day of G-CSF in Pediatric Patients with Neutropenia Induced by Chemotherapy. Pediatric Hematology and Oncology. 12(4). 393–397. 5 indexed citations
19.
Hashimoto, Hisako, Masaru Kubota, Toru Shimizu, et al.. (1992). Effect of high-dose methotrexate on plasma hypoxanthine and uridine levels in patients with acute leukemia or non-Hodgkin lymphoma in childhood.. PubMed. 6(11). 1199–202. 8 indexed citations
20.
Takahashi, Hiroshi, et al.. (1990). [A case of pulmonary metastasis from adenoid cystic carcinoma of the trachea].. PubMed. 38(6). 1063–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuka Yamamoto Breakdown of academic impact, for papers by Kenneth Russell Breakdown of academic impact, for papers by Pasquale Esposito Breakdown of academic impact, for papers by Michael H. Johnson Breakdown of academic impact, for papers by J. M. Bridges Breakdown of academic impact, for papers by Yaping Wang Breakdown of academic impact, for papers by Yves Rees Breakdown of academic impact, for papers by C. Lacombe Breakdown of academic impact, for papers by Donald W. Weaver Breakdown of academic impact, for papers by Takeshi Ishizaki
Rankless by CCL
2026